Fredun Pharmaceuticals' Senior Management will engage in an analyst and investor meeting with Nuvama Wealth and Investment Limited through a webinar. This interaction provides an avenue for the company to enhance investor relations and communicate its operational insights to institutional stakeholders. Management has confirmed that no new unpublished price sensitive information will be disclosed during this engagement, maintaining compliance while fostering transparency with the investment community.